Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects (SHIELD)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Denver Infectious Disease Consultants, PLLC.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Denver Infectious Disease Consultants, PLLC
ClinicalTrials.gov Identifier:
NCT00740064
First received: August 20, 2008
Last updated: January 27, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2009
  Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)